The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may result in the multisystem inflammatory syndrome in children (MIS-C). The clinical presentation of MIS-C includes fever, severe illness, and the involvement of two or more organ systems, in combination with laboratory evidence of inflammation and laboratory or epidemiologic evidence of SARS-CoV-2 infection. Some features of MIS-C resemble Kawasaki Disease, toxic shock syndrome, and secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome. The relationship of MIS-C to SARS-CoV-2 infection suggests that the pathogenesis involves post-infectious immune dysregulation. Patients with MIS-C should ideally be managed in a pediatric intensive care environment since rapid clinical deterioration may occur. Specific immunomodulatory therapy depends on the clinical presentation. The relationship between the immune response to SARS-CoV-2 vaccines in development and MIS-C requires further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., Baker, A. L., Jackson, M. A., Takahashi, M., Shah, P. B., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000484 · Cited by 3,723
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Hyperinflammatory shock in children during COVID-19 pandemic
Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N., & Theocharis, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31094-1 · Cited by 2,494
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., Bonanomi, E., & D'Antiga, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31103-x · Cited by 2,380
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Bialek, S., Gierke, R., Hughes, M., McNamara, L. A., Pilishvili, T., & Skoff, T. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6914e4 · Cited by 1,525
Toubiana, J., Poirault, C., Corsia, A., Bajolle, F., Fourgeaud, J., Angoulvant, F., Debray, A., Basmaci, R., Salvador, E., Biscardi, S., et al. (2020) · BMJ · doi:10.1136/bmj.m2094 · Cited by 1,144
Belhadjer, Z., Méot, M., Bajolle, F., Khraiche, D., Legendre, A., Abakka, S., Auriau, J., Grimaud, M., Oualha, M., Beghetti, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048360 · Cited by 1,129
Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease
Kobayashi, T., Inoue, Y., Takeuchi, K., Okada, Y., Tamura, K., Tomomasa, T., Kobayashi, T., & Morikawa, A. (2006) · Circulation · doi:10.1161/circulationaha.105.592865 · Cited by 889
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults
Bunyavanich, S., Do, A., & Vicencio, A. (2020) · JAMA · doi:10.1001/jama.2020.8707 · Cited by 808
Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avcin, T., Behrens, E. M., De Benedetti, F., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39332 · Cited by 773
COVID-19 and Kawasaki Disease: Novel Virus and Novel Case
Jones, V. G., Mills, M., Suarez, D., Hogan, C. A., Yeh, D., Segal, J. B., Nguyen, E. L., Barsh, G. R., Maskatia, S., & Mathew, R. (2020) · Hospital Pediatrics · doi:10.1542/hpeds.2020-0123 · Cited by 766
Kobayashi, T., Saji, T., Otani, T., Takeuchi, K., Nakamura, T., Arakawa, H., Kato, T., Hara, T., Hamaoka, K., Ogawa, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61930-2 · Cited by 676
Children with Covid-19 in Pediatric Emergency Departments in Italy
Parri, N., Lenge, M., & Buonsenso, D. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007617 · Cited by 657
On the Alert for Cytokine Storm: Immunopathology in COVID‐19
Henderson, L. A., Canna, S. W., Schulert, G. S., Volpi, S., Lee, P. Y., Kernan, K. F., Caricchio, R., Mahmud, S., Hazen, M. M., Halyabar, O., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41285 · Cited by 633
Macrophage activation syndrome in the era of biologic therapy
Grom, A. A., Horne, A., & De Benedetti, F. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.179 · Cited by 448
Recognition of a Kawasaki Disease Shock Syndrome
Kanegaye, J. T., Wilder, M. S., Molkara, D., Frazer, J. R., Pancheri, J., Tremoulet, A. H., Watson, V. E., Best, B. M., & Burns, J. C. (2009) · PEDIATRICS · doi:10.1542/peds.2008-1871 · Cited by 433
Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avcin, T., Behrens, E. M., De Benedetti, F., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208982 · Cited by 410
Association between a Novel Human Coronavirus and Kawasaki Disease
Esper, F., Shapiro, E. D., Weibel, C., Ferguson, D., Landry, M. L., & Kahn, J. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/428291 · Cited by 397
Vastert, S. J., van Wijk, R., D’Urbano, L. E., de Vooght, K. M. K., de Jager, W., Ravelli, A., Magni-Manzoni, S., Insalaco, A., Cortis, E., van Solinge, W. W., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/kep418 · Cited by 231
Marked hyperferritinemia does not predict for HLH in the adult population
Schram, A. M., Campigotto, F., Mullally, A., Fogerty, A., Massarotti, E., Neuberg, D., & Berliner, N. (2015) · Blood · doi:10.1182/blood-2014-10-602607 · Cited by 222
The Epidemiology and Pathogenesis of Kawasaki Disease
Rowley, A. H., & Shulman, S. T. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00374 · Cited by 216
Parks, T., Wilson, C., Curtis, N., Norrby-Teglund, A., & Sriskandan, S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy401 · Cited by 207
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
Antinori, S., Bonazzetti, C., Gubertini, G., Capetti, A., Pagani, C., Morena, V., Rimoldi, S., Galimberti, L., Sarzi-Puttini, P., & Ridolfo, A. L. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102564 · Cited by 183
de Graeff, N., Groot, N., Ozen, S., Eleftheriou, D., Avcin, T., Bader-Meunier, B., Dolezalova, P., Feldman, B. M., Kone-Paut, I., Lahdenne, P., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/key344 · Cited by 176
Chen, S., Dong, Y., Yin, Y., & Krucoff, M. W. (2012) · Heart · doi:10.1136/heartjnl-2012-302126 · Cited by 153
The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease
Burns, J. C., & Franco, A. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1044980 · Cited by 139
Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease
Gámez‐González, L. B., Moribe-Quintero, I. C., Cisneros-Castólo, M., Ortiz, J. V., Muñoz-Ramírez, M. C., Garrido‐García, L. M., & Yamazaki‐Nakashimada, M. A. (2018) · Pediatrics International · doi:10.1111/ped.13614 · Cited by 130
Davì, S., Minoia, F., Pistorio, A., Horne, A., Consolaro, A., Rosina, S., Bovis, F., Cimaz, R., Gámir, M. L. G., Ilowite, N. T., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38769 · Cited by 119
Halyabar, O., Chang, M. H., Schoettler, M. L., Schwartz, M. A., Barış, H. E., Benson, L. A., Biggs, C. M., Gorman, M., Lehmann, L., Lo, M. S., et al. (2019) · Pediatric Rheumatology · doi:10.1186/s12969-019-0309-6 · Cited by 110
Pediatric Coronavirus Disease-2019–Associated Multisystem Inflammatory Syndrome
Shulman, S. T. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa062 · Cited by 90
Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki’s Disease
Nozawa, T., Imagawa, T., & Ito, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1709609 · Cited by 68
Beverley, P. C. L. (2002) · British Medical Bulletin · doi:10.1093/bmb/62.1.15 · Cited by 53
Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
Evans, J., Steel, L., Borg, F., et al. (2016) · RMD Open · doi:10.1136/rmdopen-2015-000137 · Cited by 44
The long road to protect infants against severe RSV lower respiratory tract illness
Baglivo, S. J., & Polack, F. P. (2019) · F1000Research · doi:10.12688/f1000research.18749.1 · Cited by 41
DNA Viremia Is Associated with Hyperferritinemia in Pediatric Sepsis
Simon, D. W., Halstead, E. S., Davila, S., Kernan, K. F., Clark, R. S. B., Storch, G. A., & Carcillo, J. A. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.06.033 · Cited by 28
Hemophagocytic Lymphohistiocytosis and Infections: An Update
Chesshyre, E. L. D., Ramanan, A. V., & Roderick, M. R. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002248 · Cited by 23
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Kabeerdoss, J., Pilania, R. K., Karkhele, R., Kumar, T. S., Danda, D., & Singh, S. (2021) · Rheumatology International · doi:10.1007/s00296-020-04749-4 · Cited by 352
A guide to immunotherapy for COVID-19
van de Veerdonk, F. L., Giamarellos-Bourboulis, E., Pickkers, P., Derde, L., Leavis, H., van Crevel, R., Engel, J. J., Wiersinga, W. J., Vlaar, A. P. J., Shankar-Hari, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01643-9 · Cited by 320
Costagliola, G., Spada, E., & Consolini, R. (2021) · Immunity, Inflammation and Disease · doi:10.1002/iid3.404 · Cited by 81
Metadata
- Authors
- Nakra, N., Blumberg, D., Herrera-Guerra, A., & Lakshminrusimha, S.
- Venue
- Children
- Publisher
- MDPI AG
- Published
- 2020-07-01
- Volume
- 7
- Issue
- 7
- Pages
- 69
- ISSN
- 2227-9067 (ISSN-L)
- OpenAlex
- W3040117178
- Cited by
- 512
- References
- 42
- FWCI
- 89.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.